{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:24:44Z","timestamp":1788870284678,"version":"build-2803163510"},"reference-count":196,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"M.I.U.R."},{"name":"Regione Campania CISI-Lab"}],"content-domain":{"domain":["bmn.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Opinion in Pharmacology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.coph.2014.07.002","type":"journal-article","created":{"date-parts":[[2014,7,24]],"date-time":"2014-07-24T07:25:18Z","timestamp":1406186718000},"page":"45-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Immunopharmacological modulation of mast cells"],"prefix":"10.1016","volume":"17","author":[{"given":"Francesco","family":"Borriello","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francescopaolo","family":"Granata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilda","family":"Varricchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arturo","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Triggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianni","family":"Marone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.coph.2014.07.002_bib0005","series-title":"Mast Cells and Basophils","author":"Marone","year":"2000"},{"key":"10.1016\/j.coph.2014.07.002_bib0010","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1146\/annurev.immunol.21.120601.141025","article-title":"Mast cells as \u2018tunable\u2019 effector and immunoregulatory cells: recent advances","volume":"23","author":"Galli","year":"2005","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0015","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.4049\/jimmunol.146.5.1410","article-title":"Demonstration of the origin of human mast cells from CD34+ bone marrow progenitor cells","volume":"146","author":"Kirshenbaum","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0020","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1182\/blood.V84.8.2489.2489","article-title":"Mast cells cultured from the peripheral blood of normal donors and patients with mastocytosis originate from a CD34+\/Fc epsilon RI- cell population","volume":"84","author":"Rottem","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.coph.2014.07.002_bib0025","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V80.9.2237.2237","article-title":"Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor\/kit-ligand in long-term culture","volume":"80","author":"Valent","year":"1992","journal-title":"Blood"},{"key":"10.1016\/j.coph.2014.07.002_sbref0030","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/nm.2755","article-title":"IgE and mast cells in allergic disease","volume":"18","author":"Galli","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2014.07.002_bib0035","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1182\/blood-2007-11-078097","article-title":"Mast cells and mastocytosis","volume":"112","author":"Metcalfe","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.coph.2014.07.002_sbref0040","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.it.2012.09.008","article-title":"New models for analyzing mast cell functions in vivo","volume":"33","author":"Reber","year":"2012","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0045","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.immuni.2011.03.028","article-title":"Mast cells are key promoters of contact allergy that mediate the adjuvant effects of haptens","volume":"34","author":"Dudeck","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.coph.2014.07.002_bib0050","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.immuni.2011.09.015","article-title":"Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity","volume":"35","author":"Feyerabend","year":"2011","journal-title":"Immunity"},{"key":"10.1016\/j.coph.2014.07.002_bib0055","doi-asserted-by":"crossref","first-page":"6930","DOI":"10.1182\/blood-2011-03-343962","article-title":"Reduced mast cell and basophil numbers and function in Cpa3-Cre; Mcl-1fl\/fl mice","volume":"118","author":"Lilla","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coph.2014.07.002_bib0060","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/j.jaci.2009.01.044","article-title":"Vascular endothelial growth factors synthesized by human lung mast cells exert angiogenic effects","volume":"123","author":"Detoraki","year":"2009","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0065","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1038\/onc.2010.348","article-title":"Mast cells have a protumorigenic role in human thyroid cancer","volume":"29","author":"Melillo","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.coph.2014.07.002_bib0070","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1182\/blood-2012-03-415638","article-title":"Mast cells play a protumorigenic role in primary cutaneous lymphoma","volume":"120","author":"Rabenhorst","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.coph.2014.07.002_bib0075","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/j.1398-9995.2008.01768.x","article-title":"AllergoOncology: the role of IgE-mediated allergy in cancer","volume":"63","author":"Jensen-Jarolim","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0080","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1172\/JCI46139","article-title":"Mast cell chymase reduces the toxicity of Gila monster venom, scorpion venom, and vasoactive intestinal polypeptide in mice","volume":"121","author":"Akahoshi","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coph.2014.07.002_sbref0085","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/j.immuni.2013.10.005","article-title":"A beneficial role for immunoglobulin E in host defense against honeybee venom","volume":"39","author":"Marichal","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.coph.2014.07.002_bib0090","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1126\/science.1128877","article-title":"Mast cells can enhance resistance to snake and honeybee venoms","volume":"313","author":"Metz","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.coph.2014.07.002_sbref0095","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.immuni.2013.10.006","article-title":"Bee venom phospholipase A2 induces a primary type 2 response that is dependent on the receptor ST2 and confers protective immunity","volume":"39","author":"Palm","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.coph.2014.07.002_bib0100","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.1084\/jem.20071262","article-title":"Molecular mechanism of mast cell mediated innate defense against endothelin and snake venom sarafotoxin","volume":"204","author":"Schneider","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.coph.2014.07.002_bib0105","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.mib.2011.10.007","article-title":"Plasticity in mast cell responses during bacterial infections","volume":"15","author":"Chan","year":"2012","journal-title":"Curr Opin Microbiol"},{"key":"10.1016\/j.coph.2014.07.002_bib0110","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1002\/art.1780400313","article-title":"Human synovial mast cells II. Heterogeneity of the pharmacologic effects of antiinflammatory and immunosuppressive drugs","volume":"40","author":"de Paulis","year":"1997","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.coph.2014.07.002_bib0115","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.immuni.2012.07.003","article-title":"Developmental origin and functional specialization of mast cell subsets","volume":"37","author":"Gurish","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.coph.2014.07.002_bib0120","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3389\/fimmu.2012.00119","article-title":"Mast cell chemotaxis\u2014chemoattractants and signaling pathways","volume":"3","author":"Halova","year":"2012","journal-title":"Front Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaci.2014.03.007","article-title":"Molecular targets on mast cells and basophils for novel therapies","author":"Harvima","year":"2014","journal-title":"J Allergy Clin Immunol"},{"issue":"Suppl. 1","key":"10.1016\/j.coph.2014.07.002_bib0130","doi-asserted-by":"crossref","first-page":"S297","DOI":"10.1038\/sj.bjp.0706437","article-title":"Drugs for asthma","volume":"147","author":"Barnes","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2014.07.002_bib0135","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0091-6749(99)70269-1","article-title":"Effect of beta-agonists on inflammatory cells","volume":"104","author":"Barnes","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000236122","article-title":"Comparison of the modulatory effect of ketotifen, sodium cromoglycate, procaterol and salbutamol in human skin, lung and tonsil mast cells","volume":"97","author":"Okayama","year":"1992","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0145","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1046\/j.1365-2222.1998.00394.x","article-title":"The effects of anti-asthma drugs on mediator release from cultured human mast cells","volume":"28","author":"Shichijo","year":"1998","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0150","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1440-1681.2006.04435.x","article-title":"Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells","volume":"33","author":"Wang","year":"2006","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.coph.2014.07.002_bib0155","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1476-5381.2009.00178.x","article-title":"The long-acting beta-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells","volume":"158","author":"Scola","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2014.07.002_bib0160","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1182\/blood.V87.6.2262.bloodjournal8762262","article-title":"The role of stem cell factor (c-kit ligand) and inflammatory cytokines in pulmonary mast cell activation","volume":"87","author":"Lukacs","year":"1996","journal-title":"Blood"},{"key":"10.1016\/j.coph.2014.07.002_bib0165","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1111\/j.1398-9995.1994.tb00784.x","article-title":"Effect of cytokines on mediator release from human dispersed lung mast cells","volume":"49","author":"Takaishi","year":"1994","journal-title":"Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0170","doi-asserted-by":"crossref","first-page":"e251","DOI":"10.1016\/j.jaci.2009.08.020","article-title":"Counterregulation of beta(2)-adrenoceptor function in human mast cells by stem cell factor","volume":"125","author":"Cruse","year":"2010","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0175","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.4049\/jimmunol.163.5.2799","article-title":"Stem cell factor is localized in, released from, and cleaved by human mast cells","volume":"163","author":"de Paulis","year":"1999","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0180","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1365-2222.2004.01975.x","article-title":"The expression of stem cell factor and c-kit receptor in human asthmatic airways","volume":"34","author":"Al-Muhsen","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0185","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2222.2006.02431.x","article-title":"Effect of glucocorticoids on stem cell factor expression in human asthmatic bronchi","volume":"36","author":"Da Silva","year":"2006","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0190","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.coph.2012.02.016","article-title":"Selective PDE inhibitors as novel treatments for respiratory diseases","volume":"12","author":"Page","year":"2012","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/j.coph.2014.07.002_bib0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.aller.2013.07.011","article-title":"Regulation of human skin mast cell histamine release by PDE inhibitors","author":"Eskandari","year":"2013","journal-title":"Allergol Immunopathol (Madr)"},{"key":"10.1016\/j.coph.2014.07.002_bib0200","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bjp.0701115","article-title":"Effects of phosphodiesterase inhibitors on human lung mast cell and basophil function","volume":"121","author":"Weston","year":"1997","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2014.07.002_bib0205","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1136\/bmj.1.6013.820","article-title":"Cromoglycate and other antiallergic drugs: a possible mechanism of action","volume":"1","author":"Foreman","year":"1976","journal-title":"Br Med J"},{"key":"10.1016\/j.coph.2014.07.002_bib0210","doi-asserted-by":"crossref","first-page":"6014","DOI":"10.1073\/pnas.80.19.6014","article-title":"Restoration of Ca2+ influx and degranulation capacity of variant RBL-2H3 cells upon implantation of isolated cromolyn binding protein","volume":"80","author":"Mazurek","year":"1983","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2014.07.002_sbref0215","doi-asserted-by":"crossref","first-page":"e58963","DOI":"10.1371\/journal.pone.0058963","article-title":"Anti-allergic cromones inhibit histamine and eicosanoid release from activated human and murine mast cells by releasing Annexin A1","volume":"8","author":"Yazid","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coph.2014.07.002_bib0220","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1161\/ATVBAHA.110.209536","article-title":"Antiallergic cromones inhibit neutrophil recruitment onto vascular endothelium via annexin-A1 mobilization","volume":"30","author":"Yazid","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.coph.2014.07.002_bib0225","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/j.bcp.2009.03.010","article-title":"Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1","volume":"77","author":"Yazid","year":"2009","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.coph.2014.07.002_bib0230","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1038\/labinvest.2012.116","article-title":"Evidence questioning cromolyn's effectiveness and selectivity as a \u2018mast cell stabilizer\u2019 in mice","volume":"92","author":"Oka","year":"2012","journal-title":"Lab Invest"},{"key":"10.1016\/j.coph.2014.07.002_sbref0235","doi-asserted-by":"crossref","first-page":"4456","DOI":"10.1021\/jm400115k","article-title":"Design, synthesis, and inhibitory activity of potent, photoswitchable mast cell activation inhibitors","volume":"56","author":"Velema","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.coph.2014.07.002_bib0240","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/j.jaci.2007.10.041","article-title":"Glucocorticoid actions on airway epithelial responses in immunity: functional outcomes and molecular targets","volume":"120","author":"Stellato","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_sbref0245","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.mce.2013.05.014","article-title":"Molecular mechanisms of glucocorticoid action in mast cells","volume":"380","author":"Oppong","year":"2013","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.coph.2014.07.002_bib0250","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.4049\/jimmunol.136.4.1385","article-title":"Decrease in IgE Fc receptor expression on mouse bone marrow-derived mast cells and inhibition of paf-acether formation and of beta-hexosaminidase release by dexamethasone","volume":"136","author":"Benhamou","year":"1986","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0255","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.4049\/jimmunol.135.4.2719","article-title":"Regulation of mediator release from mouse bone marrow-derived mast cells by glucocorticoids","volume":"135","author":"Robin","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0260","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/intimm\/13.7.843","article-title":"Regulation of mouse mast cell surface Fc epsilon RI expression by dexamethasone","volume":"13","author":"Yamaguchi","year":"2001","journal-title":"Int Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0265","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1111\/j.1398-9995.2008.01725.x","article-title":"Glucocorticoids inhibit degranulation of mast cells in allergic asthma via nongenomic mechanism","volume":"63","author":"Zhou","year":"2008","journal-title":"Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0270","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/BF01536749","article-title":"Corticosteroid treatment reduces mast cell numbers in inflammatory bowel disease","volume":"35","author":"Goldsmith","year":"1990","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.coph.2014.07.002_bib0275","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.4049\/jimmunol.135.4.2368","article-title":"Cutaneous mast cell depletion results from topical corticosteroid usage","volume":"135","author":"Lavker","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0280","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1172\/JCI119336","article-title":"Glucocorticoids decrease tissue mast cell number by reducing the production of the c-kit ligand, stem cell factor, by resident cells: in vitro and in vivo evidence in murine systems","volume":"99","author":"Finotto","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/j.coph.2014.07.002_bib0285","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1124\/mol.54.6.1073","article-title":"Up- and down-regulation by glucocorticoids of the constitutive expression of the mast cell growth factor stem cell factor by human lung fibroblasts in culture","volume":"54","author":"Kassel","year":"1998","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.coph.2014.07.002_bib0290","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4049\/jimmunol.154.3.1391","article-title":"Dexamethasone or cyclosporin A suppress mast cell-leukocyte cytokine cascades. Multiple mechanisms of inhibition of IgE- and mast cell-dependent cutaneous inflammation in the mouse","volume":"154","author":"Wershil","year":"1995","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0295","doi-asserted-by":"crossref","first-page":"7233","DOI":"10.4049\/jimmunol.0801375","article-title":"Dexamethasone FK506 inhibit expression of distinct subsets of chemokines in human mast cells","volume":"182","author":"Kato","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0300","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jaci.2005.08.042","article-title":"Monomeric IgE enhances human mast cell chemokine production: IL-4 augments and dexamethasone suppresses the response","volume":"116","author":"Matsuda","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0305","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/S0022-3565(25)39405-X","article-title":"Nimesulide, a sulfonanilide nonsteroidal anti-inflammatory drug, inhibits mediator release from human basophils and mast cells","volume":"267","author":"Casolaro","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2014.07.002_bib0310","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4049\/jimmunol.157.3.1219","article-title":"Eosinophil granule proteins activate human heart mast cells","volume":"157","author":"Patella","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0315","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2165\/00003495-198836060-00004","article-title":"Nimesulide. A preliminary review of its pharmacological properties and therapeutic efficacy in inflammation and pain states","volume":"36","author":"Ward","year":"1988","journal-title":"Drugs"},{"key":"10.1016\/j.coph.2014.07.002_bib0320","first-page":"29","article-title":"Tolerability of nimesulide in aspirin-sensitive patients","volume":"72","author":"Andri","year":"1994","journal-title":"Ann Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0325","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1517\/14656566.1.2.277","article-title":"Nimesulide: an NSAID that preferentially inhibits COX-2, and has various unique pharmacological activities","volume":"1","author":"Bennett","year":"2000","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.coph.2014.07.002_bib0330","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nri2974","article-title":"The outs and the ins of sphingosine-1-phosphate in immunity","volume":"11","author":"Spiegel","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0335","doi-asserted-by":"crossref","first-page":"4193","DOI":"10.1182\/blood-2007-09-115451","article-title":"Distinct roles of sphingosine kinases 1 and 2 in human mast-cell functions","volume":"111","author":"Oskeritzian","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.coph.2014.07.002_bib0340","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/380634a0","article-title":"Calcium mobilization via sphingosine kinase in signalling by the Fc epsilon RI antigen receptor","volume":"380","author":"Choi","year":"1996","journal-title":"Nature"},{"key":"10.1016\/j.coph.2014.07.002_bib0345","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1084\/jem.20030680","article-title":"Transactivation of sphingosine-1-phosphate receptors by FcepsilonRI triggering is required for normal mast cell degranulation and chemotaxis","volume":"199","author":"Jolly","year":"2004","journal-title":"J Exp Med"},{"key":"10.1016\/j.coph.2014.07.002_bib0350","doi-asserted-by":"crossref","first-page":"17255","DOI":"10.1074\/jbc.M110944200","article-title":"Dichotomy of Ca2+ signals triggered by different phospholipid pathways in antigen stimulation of human mast cells","volume":"277","author":"Melendez","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2014.07.002_bib0355","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.immuni.2007.02.008","article-title":"The sphingosine kinase-sphingosine-1-phosphate axis is a determinant of mast cell function and anaphylaxis","volume":"26","author":"Olivera","year":"2007","journal-title":"Immunity"},{"key":"10.1016\/j.coph.2014.07.002_bib0360","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1074\/jbc.M508931200","article-title":"IgE-dependent activation of sphingosine kinases 1 and 2 and secretion of sphingosine 1-phosphate requires Fyn kinase and contributes to mast cell responses","volume":"281","author":"Olivera","year":"2006","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2014.07.002_bib0365","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4049\/jimmunol.0803430","article-title":"Sphingosine kinase 1 is pivotal for Fc epsilon RI-mediated mast cell signaling and functional responses in vitro and in vivo","volume":"183","author":"Pushparaj","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_sbref0370","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jaci.2012.07.014","article-title":"A specific sphingosine kinase 1 inhibitor attenuates airway hyperresponsiveness and inflammation in a mast cell-dependent murine model of allergic asthma","volume":"131","author":"Price","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0375","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2006.11.701","article-title":"TNF can contribute to multiple features of ovalbumin-induced allergic inflammation of the airways in mice","volume":"119","author":"Nakae","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0380","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1084\/jem.192.3.455","article-title":"Mast cells can amplify airway reactivity and features of chronic inflammation in an asthma model in mice","volume":"192","author":"Williams","year":"2000","journal-title":"J Exp Med"},{"key":"10.1016\/j.coph.2014.07.002_bib0385","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-065X.2008.00742.x","article-title":"The tyrosine kinase network regulating mast cell activation","volume":"228","author":"Gilfillan","year":"2009","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coph.2014.07.002_bib0390","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/0092-8674(90)90303-V","article-title":"The hematopoietic growth factor KL is encoded by the Sl locus and is the ligand of the c-kit receptor, the gene product of the W locus","volume":"63","author":"Huang","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.coph.2014.07.002_bib0395","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0092-8674(90)90302-U","article-title":"Stem cell factor is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor","volume":"63","author":"Zsebo","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.coph.2014.07.002_bib0400","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/0092-8674(90)90300-4","article-title":"Identification, purification, and biological characterization of hematopoietic stem cell factor from buffalo rat liver\u2014conditioned medium","volume":"63","author":"Zsebo","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.coph.2014.07.002_bib0405","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/0092-8674(90)90304-W","article-title":"Molecular cloning of mast cell growth factor, a hematopoietin that is active in both membrane bound and soluble forms","volume":"63","author":"Anderson","year":"1990","journal-title":"Cell"},{"key":"10.1016\/j.coph.2014.07.002_bib0410","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.coph.2014.07.002_bib0415","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.coph.2014.07.002_bib0420","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1182\/blood.V99.5.1741","article-title":"The c-KIT mutation causing human mastocytosis is resistant to STI571 and other KIT kinase inhibitors; kinases with enzymatic site mutations show different inhibitor sensitivity profiles than wild-type kinases and those with regulatory-type mutations","volume":"99","author":"Ma","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.coph.2014.07.002_bib0425","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.leukres.2011.05.006","article-title":"Tyrosine kinase inhibitors in the treatment of systemic mastocytosis","volume":"35","author":"Ustun","year":"2011","journal-title":"Leuk Res"},{"key":"10.1016\/j.coph.2014.07.002_sbref0430","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1038\/leu.2012.218","article-title":"Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activation","volume":"27","author":"Bai","year":"2013","journal-title":"Leukemia"},{"key":"10.1016\/j.coph.2014.07.002_bib0435","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.3324\/haematol.2012.079202","article-title":"Synergistic growth-inhibitory effects of ponatinib and midostaurin (PKC412) on neoplastic mast cells carrying KIT D816V","volume":"98","author":"Gleixner","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.coph.2014.07.002_bib0440","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejphar.2012.01.039","article-title":"Anti-allergic effects of nilotinib on mast cell-mediated anaphylaxis like reactions","volume":"680","author":"El-Agamy","year":"2012","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.coph.2014.07.002_bib0445","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1111\/j.1398-9995.2011.02717.x","article-title":"Tyrosine kinase inhibitor sunitinib relieves systemic and oral antigen-induced anaphylaxes in mice","volume":"67","author":"Yamaki","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0450","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1124\/jpet.107.125237","article-title":"Concurrent inhibition of kit- and FcepsilonRI-mediated signaling: coordinated suppression of mast cell activation","volume":"324","author":"Jensen","year":"2008","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2014.07.002_bib0455","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/j.1365-2222.2010.03667.x","article-title":"Characterization of syk expression in human lung mast cells: relationship with function","volume":"41","author":"Havard","year":"2011","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0460","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0091-6749(99)70367-2","article-title":"Syk deficiency in nonreleaser basophils","volume":"104","author":"Kepley","year":"1999","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0465","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1165\/ajrcmb.23.4.4123","article-title":"The tyrosine kinases p53\/56lyn and p72syk are differentially expressed at the protein level but not at the messenger RNA level in nonreleasing human basophils","volume":"23","author":"Lavens-Phillips","year":"2000","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.coph.2014.07.002_bib0470","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.jaci.2006.09.040","article-title":"Relationship between spleen tyrosine kinase and phosphatidylinositol 5\u2032 phosphatase expression and secretion from human basophils in the general population","volume":"119","author":"MacGlashan","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0475","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.pupt.2007.06.002","article-title":"Syk inhibitors as treatment for allergic rhinitis","volume":"21","author":"Masuda","year":"2008","journal-title":"Pulm Pharmacol Ther"},{"key":"10.1016\/j.coph.2014.07.002_bib0480","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaci.2005.01.040","article-title":"An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment","volume":"115","author":"Meltzer","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0485","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1165\/rcmb.2005-0298OC","article-title":"Syk activation in dendritic cells is essential for airway hyperresponsiveness and inflammation","volume":"34","author":"Matsubara","year":"2006","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.coph.2014.07.002_bib0490","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1164\/rccm.200503-361OC","article-title":"Inhibition of spleen tyrosine kinase prevents mast cell activation and airway hyperresponsiveness","volume":"173","author":"Matsubara","year":"2006","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.coph.2014.07.002_bib0495","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.jaci.2012.07.039","article-title":"Spleen tyrosine kinase inhibition attenuates airway hyperresponsiveness and pollution-induced enhanced airway response in a chronic mouse model of asthma","volume":"131","author":"Penton","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0500","doi-asserted-by":"crossref","first-page":"3790","DOI":"10.4049\/jimmunol.164.7.3790","article-title":"Aerosolized Syk antisense suppresses Syk expression, mediator release from macrophages, and pulmonary inflammation","volume":"164","author":"Stenton","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0505","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.4049\/jimmunol.169.2.1028","article-title":"Inhibition of allergic inflammation in the airways using aerosolized antisense to Syk kinase","volume":"169","author":"Stenton","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0510","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa1000500","article-title":"An oral spleen tyrosine kinase (Syk) inhibitor for rheumatoid arthritis","volume":"363","author":"Weinblatt","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2014.07.002_bib0515","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1182\/blood-2009-08-236471","article-title":"Inhibition of Syk with fostamatinib disodium has significant clinical activity in non-Hodgkin lymphoma and chronic lymphocytic leukemia","volume":"115","author":"Friedberg","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.coph.2014.07.002_bib0520","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nri2765","article-title":"The SYK tyrosine kinase: a crucial player in diverse biological functions","volume":"10","author":"Mocsai","year":"2010","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0525","doi-asserted-by":"crossref","first-page":"518","DOI":"10.2174\/092986611794927910","article-title":"HRV signaling in airway epithelial cells is regulated by ITAM-mediated recruitment and activation of Syk","volume":"18","author":"Lau","year":"2011","journal-title":"Protein Pept Lett"},{"key":"10.1016\/j.coph.2014.07.002_bib0530","doi-asserted-by":"crossref","first-page":"870","DOI":"10.4049\/jimmunol.180.2.870","article-title":"Syk associates with clathrin and mediates phosphatidylinositol 3-kinase activation during human rhinovirus internalization","volume":"180","author":"Lau","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0535","doi-asserted-by":"crossref","first-page":"6859","DOI":"10.4049\/jimmunol.177.10.6859","article-title":"Syk is downstream of intercellular adhesion molecule-1 and mediates human rhinovirus activation of p38 MAPK in airway epithelial cells","volume":"177","author":"Wang","year":"2006","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0540","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.3016900","article-title":"Calmodulin, cyclophilin, and cyclosporin A","volume":"233","author":"Hait","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.coph.2014.07.002_bib0545","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/346671a0","article-title":"Molecular cloning and overexpression of the human FK506-binding protein FKBP","volume":"346","author":"Standaert","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.coph.2014.07.002_bib0550","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/357692a0","article-title":"FK-506- and CsA-sensitive activation of the interleukin-2 promoter by calcineurin","volume":"357","author":"O\u2019Keefe","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.coph.2014.07.002_bib0555","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/0092-8674(91)90124-H","article-title":"Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes","volume":"66","author":"Liu","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.coph.2014.07.002_bib0560","doi-asserted-by":"crossref","first-page":"3891","DOI":"10.4049\/jimmunol.144.10.3891","article-title":"Cyclosporin A rapidly inhibits mediator release from human basophils presumably by interacting with cyclophilin","volume":"144","author":"Cirillo","year":"1990","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0565","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.4049\/jimmunol.146.7.2374","article-title":"FK-506 a potent novel inhibitor of the release of proinflammatory mediators from human Fc epsilon RI+ cells","volume":"146","author":"de Paulis","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0570","doi-asserted-by":"crossref","first-page":"4278","DOI":"10.4049\/jimmunol.147.12.4278","article-title":"Characterization of the anti-inflammatory effect of FK-506 on human mast cells","volume":"147","author":"de Paulis","year":"1991","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0575","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/1523-1747.ep12614216","article-title":"Anti-inflammatory effect of FK-506 on human skin mast cells","volume":"99","author":"de Paulis","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coph.2014.07.002_bib0580","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1111\/1523-1747.ep12499960","article-title":"Anti-inflammatory effect of cyclosporin A on human skin mast cells","volume":"98","author":"Stellato","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coph.2014.07.002_bib0585","doi-asserted-by":"crossref","first-page":"2314","DOI":"10.1056\/NEJMcp042803","article-title":"Clinical practice. Atopic dermatitis","volume":"352","author":"Williams","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2014.07.002_bib0590","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1056\/NEJM199812103392415","article-title":"Tacrolimus ointment for atopic dermatitis","volume":"339","author":"Marone","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2014.07.002_sbref0595","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1038\/jid.2013.250","article-title":"Mast cells are required for full expression of allergen\/SEB-induced skin inflammation","volume":"133","author":"Ando","year":"2013","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.coph.2014.07.002_sbref0600","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.celrep.2013.12.029","article-title":"Critical role for mast cell Stat5 activity in skin inflammation","volume":"6","author":"Ando","year":"2014","journal-title":"Cell Rep"},{"key":"10.1016\/j.coph.2014.07.002_sbref0605","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nature12655","article-title":"Staphylococcus delta-toxin induces allergic skin disease by activating mast cells","volume":"503","author":"Nakamura","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.coph.2014.07.002_bib0610","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.coi.2009.09.006","article-title":"Mast cells in atopic dermatitis","volume":"21","author":"Toshiaki","year":"2009","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0615","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1159\/000316353","article-title":"Pimecrolimus induces apoptosis of mast cells in a murine model of cutaneous mastocytosis","volume":"153","author":"Ma","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0620","doi-asserted-by":"crossref","first-page":"14071","DOI":"10.1074\/jbc.R109.094003","article-title":"Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony","volume":"285","author":"Foster","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2014.07.002_bib0625","doi-asserted-by":"crossref","first-page":"4586","DOI":"10.4049\/jimmunol.180.7.4586","article-title":"Activation and function of the mTORC1 pathway in mast cells","volume":"180","author":"Kim","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0630","doi-asserted-by":"crossref","first-page":"6803","DOI":"10.1182\/blood-2011-06-359984","article-title":"mTORC1 and mTORC2 differentially regulate homeostasis of neoplastic and non-neoplastic human mast cells","volume":"118","author":"Smrz","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.coph.2014.07.002_bib0635","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jaci.2011.09.005","article-title":"Histamine and H1-antihistamines: celebrating a century of progress","volume":"128","author":"Simons","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0640","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0022-3565(25)30079-0","article-title":"The effects of the H1 and H2 antihistamines on \u2018allergic\u2019 histamine release and its inhibition by histamine","volume":"192","author":"Lichtenstein","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2014.07.002_bib0645","first-page":"207","article-title":"Antiinflammatory effects of oxatomide","volume":"9","author":"Marone","year":"1999","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0650","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000237340","article-title":"Oxatomide inhibits the release of proinflammatory mediators from human basophils and mast cells","volume":"111","author":"Patella","year":"1996","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0655","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.anai.2013.08.025","article-title":"Rupatadine inhibits inflammatory mediator release from human laboratory of allergic diseases 2 cultured mast cells stimulated by platelet-activating factor","volume":"111","author":"Alevizos","year":"2013","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0660","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000232569","article-title":"Rupatadine inhibits proinflammatory mediator secretion from human mast cells triggered by different stimuli","volume":"151","author":"Vasiadi","year":"2010","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0665","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1365-2222.1997.tb00745.x","article-title":"Loratadine and desethoxylcarbonyl-loratadine inhibit the immunological release of mediators from human Fc epsilon RI+ cells","volume":"27","author":"Genovese","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0670","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1038\/jid.2009.134","article-title":"Desloratadine inhibits human skin mast cell activation and histamine release","volume":"129","author":"Weller","year":"2009","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.coph.2014.07.002_bib0675","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1046\/j.1365-2222.2001.01139.x","article-title":"Cetirizine inhibits skin reactions but not mediator release in immediate and developing late-phase allergic cutaneous reactions. A double-blind, placebo-controlled study","volume":"31","author":"Nielsen","year":"2001","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0680","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/j.1398-9995.1994.tb02657.x","article-title":"In vitro effects of H1-antihistamines on histamine and PGD2 release from mast cells of human lung, tonsil, and skin","volume":"49","author":"Okayama","year":"1994","journal-title":"Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0685","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1365-2222.2004.01851.x","article-title":"Differential modulation of mediator release from human basophils and mast cells by mizolastine","volume":"34","author":"Triggiani","year":"2004","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0690","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1016\/j.jaci.2011.06.051","article-title":"Regulation of the immune response and inflammation by histamine and histamine receptors","volume":"128","author":"O\u2019Mahony","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0695","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1124\/jpet.102.046581","article-title":"Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells","volume":"305","author":"Hofstra","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2014.07.002_sbref0700","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.cellimm.2013.05.006","article-title":"Histamine receptor H4 regulates mast cell degranulation and IgE induced FcepsilonRI upregulation in murine bone marrow-derived mast cells","volume":"283","author":"Mirzahosseini","year":"2013","journal-title":"Cell Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0705","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.tips.2012.06.002","article-title":"IgE-dependent signaling as a therapeutic target for allergies","volume":"33","author":"MacGlashan","year":"2012","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.coph.2014.07.002_bib0710","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/nrd3871","article-title":"Protein kinase C, an elusive therapeutic target?","volume":"11","author":"Mochly-Rosen","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.coph.2014.07.002_bib0715","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/sj.bjp.0706207","article-title":"Protein kinase C-alpha mediates TNF release process in RBL-2H3 mast cells","volume":"145","author":"Abdel-Raheem","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.coph.2014.07.002_bib0720","doi-asserted-by":"crossref","first-page":"2624","DOI":"10.4049\/jimmunol.159.6.2624","article-title":"Functional effects of overexpression of protein kinase C-alpha, -beta, -delta -epsilon, and -eta in the mast cell line RBL-2H3","volume":"159","author":"Chang","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0725","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.cellimm.2005.12.001","article-title":"Protein kinase C alpha, betaI, and betaII isozymes regulate cytokine production in mast cells through MEKK2\/ERK5-dependent and -independent pathways","volume":"238","author":"Li","year":"2005","journal-title":"Cell Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0730","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1189\/jlb.69.5.831","article-title":"Protein kinase C theta is expressed in mast cells and is functionally involved in Fcepsilon receptor I signaling","volume":"69","author":"Liu","year":"2001","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.coph.2014.07.002_bib0735","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1182\/blood.V95.5.1752.005k18_1752_1757","article-title":"Inhibition of degranulation and interleukin-6 production in mast cells derived from mice deficient in protein kinase Cbeta","volume":"95","author":"Nechushtan","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.coph.2014.07.002_bib0740","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1016\/S0021-9258(18)53916-8","article-title":"Ca(2+)-dependent and Ca(2+)-independent isozymes of protein kinase C mediate exocytosis in antigen-stimulated rat basophilic RBL-2H3 cells. Reconstitution of secretory responses with Ca2+ and purified isozymes in washed permeabilized cells","volume":"268","author":"Ozawa","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2014.07.002_bib0745","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/313059a0","article-title":"Protein kinase C regulation of the receptor-coupled calcium signal in histamine-secreting rat basophilic leukaemia cells","volume":"313","author":"Sagi-Eisenberg","year":"1985","journal-title":"Nature"},{"key":"10.1016\/j.coph.2014.07.002_bib0750","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.1128\/MCB.22.12.3970-3980.2002","article-title":"Protein kinase C-delta is a negative regulator of antigen-induced mast cell degranulation","volume":"22","author":"Leitges","year":"2002","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.coph.2014.07.002_bib0755","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1016\/S0021-9258(18)53768-6","article-title":"Different isozymes of protein kinase C mediate feedback inhibition of phospholipase C and stimulatory signals for exocytosis in rat RBL-2H3 cells","volume":"268","author":"Ozawa","year":"1993","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2014.07.002_bib0760","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1182\/blood.V85.5.1272.bloodjournal8551272","article-title":"The antineoplastic bryostatins affect human basophils and mast cells differently","volume":"85","author":"Patella","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.coph.2014.07.002_bib0765","first-page":"827","article-title":"Expression and function of angiopoietins and their tie receptors in human basophils and mast cells","volume":"27","author":"Prevete","year":"2013","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/j.coph.2014.07.002_bib0770","doi-asserted-by":"crossref","first-page":"570","DOI":"10.4049\/jimmunol.126.2.570","article-title":"Release of histamine from human leukocytes stimulated with the tumor-promoting phorbol diesters. I. Characterization of the response","volume":"126","author":"Schleimer","year":"1981","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0775","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0022-3565(25)20375-5","article-title":"Protein kinase C modulates immunoglobulin E-mediated activation of human mast cells from lung and skin. I. Pharmacologic inhibition","volume":"258","author":"Massey","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.coph.2014.07.002_bib0780","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1042\/BJ20130220","article-title":"Protein kinase C pharmacology: refining the toolbox","volume":"452","author":"Wu-Zhang","year":"2013","journal-title":"Biochem J"},{"key":"10.1016\/j.coph.2014.07.002_bib0785","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1111\/cea.12043","article-title":"Ion channels regulating mast cell biology","volume":"43","author":"Ashmole","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0790","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1136\/thx.2006.060319","article-title":"Functional KCa3.1 K+ channels are required for human lung mast cell migration","volume":"61","author":"Cruse","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.coph.2014.07.002_sbref0795","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.jaci.2012.01.070","article-title":"CRACM\/Orai ion channel expression and function in human lung mast cells","volume":"129","author":"Ashmole","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0800","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1038\/nri2152","article-title":"Calcium signalling in lymphocyte activation and disease","volume":"7","author":"Feske","year":"2007","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0805","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1398-9995.2004.00772.x","article-title":"Benefits of omalizumab as add-on therapy in patients with severe persistent asthma who are inadequately controlled despite best available therapy (GINA 2002 step 4 treatment): INNOVATE","volume":"60","author":"Humbert","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.coph.2014.07.002_bib0810","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jaci.2004.06.032","article-title":"Omalizumab-induced reductions in mast cell Fce psilon RI expression and function","volume":"114","author":"Beck","year":"2004","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0815","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.4049\/jimmunol.158.3.1438","article-title":"Down-regulation of Fc(epsilon)RI expression on human basophils during in vivo treatment of atopic patients with anti-IgE antibody","volume":"158","author":"MacGlashan","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0820","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.jaci.2003.10.003","article-title":"Omalizumab treatment downregulates dendritic cell FcepsilonRI expression","volume":"112","author":"Prussin","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0825","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jaci.2008.07.006","article-title":"Treatment of chronic autoimmune urticaria with omalizumab","volume":"122","author":"Kaplan","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_sbref0830","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa1215372","article-title":"Omalizumab for the treatment of chronic idiopathic or spontaneous urticaria","volume":"368","author":"Maurer","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.coph.2014.07.002_bib0835","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jaci.2007.11.026","article-title":"Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy","volume":"121","author":"Corren","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0840","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/nsb0596-419","article-title":"Structure based design and characterization of peptides that inhibit IgE binding to its high-affinity receptor","volume":"3","author":"McDonnell","year":"1996","journal-title":"Nat Struct Biol"},{"key":"10.1016\/j.coph.2014.07.002_bib0845","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.molimm.2007.04.020","article-title":"Anti-allergic properties of a new all-D synthetic immunoglobulin-binding peptide","volume":"45","author":"Rossi","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0850","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1016\/j.molimm.2009.07.025","article-title":"IgE-binding properties and selectivity of peptide mimics of the FcvarepsilonRI binding site","volume":"46","author":"Sandomenico","year":"2009","journal-title":"Mol Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0855","doi-asserted-by":"crossref","first-page":"221","DOI":"10.4049\/jimmunol.157.1.221","article-title":"High-affinity oligonucleotide ligands to human IgE inhibit binding to Fc epsilon receptor I","volume":"157","author":"Wiegand","year":"1996","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0860","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.imlet.2010.07.005","article-title":"DARPins against a functional IgE epitope","volume":"133","author":"Baumann","year":"2010","journal-title":"Immunol Lett"},{"key":"10.1016\/j.coph.2014.07.002_bib0865","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/j.jmb.2009.08.014","article-title":"DARPins as bispecific receptor antagonists analyzed for immunoglobulin E receptor blockage","volume":"393","author":"Eggel","year":"2009","journal-title":"J Mol Biol"},{"key":"10.1016\/j.coph.2014.07.002_sbref0870","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/nature11546","article-title":"Accelerated disassembly of IgE-receptor complexes by a disruptive macromolecular inhibitor","volume":"491","author":"Kim","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.coph.2014.07.002_bib0875","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1600-065X.2008.00666.x","article-title":"Immunoreceptor tyrosine-based inhibition motifs: a quest in the past and future","volume":"224","author":"Daeron","year":"2008","journal-title":"Immunol Rev"},{"key":"10.1016\/j.coph.2014.07.002_bib0880","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/978-1-4419-9533-9_9","article-title":"Down-regulation of mast cell responses through ITIM containing inhibitory receptors","volume":"716","author":"Karra","year":"2011","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.coph.2014.07.002_bib0885","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nm0502-518","article-title":"A novel human immunoglobulin Fc gamma Fc epsilon bifunctional fusion protein inhibits Fc epsilon RI-mediated degranulation","volume":"8","author":"Zhu","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.coph.2014.07.002_bib0890","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.it.2009.02.003","article-title":"The CD300 family of molecules are evolutionarily significant regulators of leukocyte functions","volume":"30","author":"Clark","year":"2009","journal-title":"Trends Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0895","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0006-291X(03)01245-2","article-title":"Identification and characterization of a new pair of immunoglobulin-like receptors LMIR1 and 2 derived from murine bone marrow-derived mast cells","volume":"307","author":"Kumagai","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.coph.2014.07.002_bib0900","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.4049\/jimmunol.175.12.7989","article-title":"The inhibitory receptor IRp60 (CD300a) is expressed and functional on human mast cells","volume":"175","author":"Bachelet","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0905","doi-asserted-by":"crossref","first-page":"6064","DOI":"10.4049\/jimmunol.180.9.6064","article-title":"Suppression of normal and malignant kit signaling by a bispecific antibody linking kit with CD300a","volume":"180","author":"Bachelet","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0910","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jaci.2006.04.031","article-title":"Abrogation of allergic reactions by a bispecific antibody fragment linking IgE to CD300a","volume":"117","author":"Bachelet","year":"2006","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_sbref0915","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1182\/blood-2011-08-372425","article-title":"Human CD300a binds to phosphatidylethanolamine and phosphatidylserine, and modulates the phagocytosis of dead cells","volume":"119","author":"Simhadri","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.coph.2014.07.002_bib0920","doi-asserted-by":"crossref","first-page":"7662","DOI":"10.1074\/jbc.M112.434746","article-title":"Human CD300C delivers an Fc receptor-gamma-dependent activating signal in mast cells and monocytes and differs from CD300A in ligand recognition","volume":"288","author":"Takahashi","year":"2013","journal-title":"J Biol Chem"},{"key":"10.1016\/j.coph.2014.07.002_sbref0925","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1084\/jem.20120096","article-title":"Apoptotic cells suppress mast cell inflammatory responses via the CD300a immunoreceptor","volume":"209","author":"Nakahashi-Oda","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/j.coph.2014.07.002_sbref0930","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jaci.2013.08.008","article-title":"Sphingomyelin and ceramide are physiological ligands for human LMIR3\/CD300f, inhibiting FcepsilonRI-mediated mast cell activation","volume":"133","author":"Izawa","year":"2014","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_sbref0935","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.immuni.2012.08.018","article-title":"The receptor LMIR3 negatively regulates mast cell activation and allergic responses by binding to extracellular ceramide","volume":"37","author":"Izawa","year":"2012","journal-title":"Immunity"},{"key":"10.1016\/j.coph.2014.07.002_bib0940","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.pharmthera.2012.06.005","article-title":"Siglec-8 as a drugable target to treat eosinophil and mast cell-associated conditions","volume":"135","author":"Kiwamoto","year":"2012","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.coph.2014.07.002_bib0945","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jaci.2007.10.004","article-title":"Inhibition of FcepsilonRI-dependent mediator release and calcium flux from human mast cells by sialic acid-binding immunoglobulin-like lectin 8 engagement","volume":"121","author":"Yokoi","year":"2008","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0950","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.4049\/jimmunol.0902450","article-title":"CD72 negatively regulates KIT-mediated responses in human mast cells","volume":"184","author":"Kataoka","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0955","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s10875-008-9264-6","article-title":"CD72 a coreceptor with both positive and negative effects on B lymphocyte development and function","volume":"29","author":"Wu","year":"2009","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0960","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/ni.1886","article-title":"An immunoglobulin-like receptor Allergin-1, inhibits immunoglobulin E-mediated immediate hypersensitivity reactions","volume":"11","author":"Hitomi","year":"2010","journal-title":"Nat Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0965","doi-asserted-by":"crossref","first-page":"e76160","DOI":"10.1371\/journal.pone.0076160","article-title":"Expression and function of Allergin-1 on human primary mast cells","volume":"8","author":"Nagai","year":"2013","journal-title":"PLOS ONE"},{"key":"10.1016\/j.coph.2014.07.002_bib0970","first-page":"62","article-title":"LAMP-1 and LAMP-2, but not LAMP-3, are reliable markers for activation-induced secretion of human mast cells","volume":"61","author":"Andreas","year":"2004","journal-title":"Cytometry"},{"key":"10.1016\/j.coph.2014.07.002_bib0975","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/S0161-5890(02)00080-9","article-title":"An unusual inhibitory receptor\u2014the mast cell function-associated antigen (MAFA)","volume":"38","author":"Abramson","year":"2002","journal-title":"Mol Immunol"},{"key":"10.1016\/j.coph.2014.07.002_bib0980","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/sj.emboj.7600932","article-title":"Selective inhibition of the Fc epsilon RI-induced de novo synthesis of mediators by an inhibitory receptor","volume":"25","author":"Abramson","year":"2006","journal-title":"EMBO J"}],"container-title":["Current Opinion in Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489214000770?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1471489214000770?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T18:44:19Z","timestamp":1746297859000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1471489214000770"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":196,"alternative-id":["S1471489214000770"],"URL":"https:\/\/doi.org\/10.1016\/j.coph.2014.07.002","relation":{},"ISSN":["1471-4892"],"issn-type":[{"value":"1471-4892","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Immunopharmacological modulation of mast cells","name":"articletitle","label":"Article Title"},{"value":"Current Opinion in Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.coph.2014.07.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}